Stocktitan

Published September 23, 2026

[6-K] PSYENCE BIOMEDICAL LTD. Current Report (Foreign Issuer) | PBM SEC Filing

Read the full story at Stocktitan

The Texas Ibogaine Research Corporation has been established as a company subsidiary, but a potential Texas ibogaine trial remains under feasibility.